RxDoctor Payments Data

Stephen Kovacs, MD

MOHS-Micrographic Surgery · Brighton, MANPI 1124014006

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Johnson & Johnson. That places this record below the midpoint for mohs-micrographic surgery clinicians in MA, where the typical reported total is $746.

$475in general payments, 2019–2025

Across 6 payments — averaging $79.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$475

What the payments were for

  • Food & beverage$475100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson6$475

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$475 in reported general payments places this provider in the 40th percentile of 38 mohs-micrographic surgery providers in Massachusetts.

See all mohs-micrographic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$649,536
Medicare patients
434
Services billed
2,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Triamcinolone Acetonide24$209
Cephalexin22$176
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$142
Minocycline Hcl13$95

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Brighton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →